DIFFERENTIAL EXPRESSION OF PREDICTIVE VARIABLES OF MEDICAL IMPORTANCE AND THEIR INTERPLAY TO DEVELOP RHEUMATOID ARTHRITIS

Main Article Content

Sheikh Khurram Salam Sehgal
Hina Allah Ditta
Asia Hussain
Tariq Hussain
Rihana Dilshad
Amina Jawaid
Arif Malik
Ayesha Zahid

Keywords

Rheumatoid Arthritis, Autoimmune Disease, MDA, 8-OHdG, 4-HNE

Abstract

INTRODUCTION: Rheumatoid arthritis (RA) is an inflammatory disorder that may be characterized by an autoimmune multisystem disease. Other important characteristic features include inflammation of synovial membrane of joints followed by the pain and swelling. Primary aim of the current study is to elucidate the effects of various predictive variables in the development of the rheumatoid arthritis and their differential expression in blood, saliva and synovial fluid of the subjects.


MATERIALS AND METHODS: For the current study fifty (n=50) patients of clinically diagnosed (RA) along with fifty (n=50) age and sex matched individuals were included. blood, saliva and synovial fluid samples were collected from Jinnah hospital Lahore and were stored at -70օC until assayed. All of the experimental protocols were approved by research ethical committee of Institute of Molecular biology and Biotechnology (IMBB) University of Lahore. Levels of Malondialdehyde (MDA), Isoprostanes, 8-Hydroxy-2-Deoxyguanosine (8-OHdG) and 4-Hydroxynonenal (4-HNE) were estimated by their respective spectrophotometric and ELISA methods.


RESULTS: Findings of the study stated elevated levels of the said markers in the diseased group as compared to the healthy individuals. Levels remained sensitive in the synovial fluid as compared to the serum and saliva. MDA levels remained elevated in serum, saliva and synovial fluids in subjects (0.95±0.019, 0.056±0.0056, 0.019±0.0016) as compared to the controls (1.95±0.094, 0.012±0.0034, 3.26±0.65). Similarly, the levels of Isoprostanes, 8-OHdG and 4-HNE also remained higher in the subjects when compared in controls.


CONCLUSION: Findings of the study show that levels of the said markers remained higher among the patients of rheumatoid arthritis when compared with the healthy controls. Findings show that the levels remained more sensitive in the synovial fluid as compared to the serum and saliva samples thus, it may be concluded that estimation of the said variables in the synovial fluid may remain as promising variable as the indicator of early onset of the rheumatoid arthritis.

Abstract 49 | pdf Downloads 13

References

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003; 423:356-61.
2. Woolley David E. The Mast Cell in Inflammatory Arthritis. N Engl J Med. 2003;348: 1709-11.
3. Nathan CF, Murray HK, Cohn ZA. The macrophage as an effector cell. N Engl J Med. 1980;303:622-26.
4. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. Mædica. 2010;5(4):286-91.
5. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43:30-7.
6. Crowson CS, Matteson EL, Davis JM, Gabriel SE. Contribution of Obesity to the Rise in Incidence of Rheumatoid Arthritis. Arthritis care & research. 2013;65(1):71-77.
7. Greenwald RA, Moy WW. Effect of oxygen derived free radicals on hylauronic acid. Arthritis Rheum. 1980;23:455-63.
8. Bae SC, Kim SJ, Sung MK. Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr. 2003;22:311-15.
9. Marklund SL, Bjelle A, Elmqvist LG. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis. 1986;45:847-51.
10. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 1999;19:35-37.
11. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int. 2002;21:200-04.
12. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis. 1993;52:659-66.
13. Quiñonez-Flores CM, González-Chávez SA, Del Río Nájera D, Pacheco-Tena C. Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review. BioMed Research International. 2016;2016:6097417.
14. Tetik S, Ahmed S, Alturfan AA, Fresko I, Murat D, Sahin Y et al. Determination of oxidative stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. Indian journal of biochemistry & biophysics. 2010;353-358.
15. Akyol O, Iscedilc IN, Temel I, Ozg c¸men S, Uz E, Murat M. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine. 2001;68:311-7.
16. Lunec J, Jalloran SP, White AG, Dormandy TL. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol. 1981;8:233-45.
17. Sklodowska M, Gromadzinska J, Biernacka M, Will beowicz W, Wolkanin P, Marszalek A et al. Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin and Exp. Rheumatol. 1996;14:433-439.
18. Vasanthi P, Ganesan N, Hariprasad C, Rajasekhar G, Meera S. plasma lipophilic antioxidant and pro-oxidant levels in rheumatoid arthritis. J Indian Rheumatol Assoc. 2004;12:40-42.
19. Alturfan AA, Uslu E, Alturfan EE, Hatemi G, Fresko I, Kokoglu K. Increased serum sialic acid levels in primary osteoarthritis and inactive rheumatoid arthritis.Tohoku J Exp Med. 2007;213:241-48
20. Blair IA. DNA adducts with lipid peroxidation products. The Journal of Biological Chemistry. 2008;15545-49.
21. Seven A, uzel SG, Aslan M, and Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clinical Biochemistry. 2008;41:538-43.
22. Baskol G, Demir H, Baskol M. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochemistry and Function. 2006;24(4):307-11.
23. Frijhoff J, Winyard PG, Zarkovic N. Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants & Redox Signaling. 2015;23(14):1144-70.
24. Kennedy A, Fearon U, Veale DJ, Godson C. Macrophages in Synovial Inflammation. Frontiers in Immunology. 2011;2:52.
25. Gutteridge JMC. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to extracellular antioxidant activities of caeruplasmin. Biochem J. 1987;245:415-21.
26. Basu S, Whiteman M, Mattey DL, Halliwell D. Raised levels of F2-isoprostanes and prostaglandin F2á in different rheumatic diseases. Ann Rheum Dis. 2001;60:627-31
27. Selley ML, Bourne DJ, Bartlett MR, Tymms KE, Brook AS, Duffield AM et al. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1992;51:481-4.
28. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003;42:318-43.
29. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. 1997;30:351-5.
30. Akgol G, Ulusoy H, Telo S, Gulkesen A, Yildirim T, Poyraz AK, et al. Is 4-Hydroxynonenal a Predictive Parameter for the Development of Joint Erosion in Patients With Rheumatoid Arthritis? Arch Rheumatol. 2016;31(1):76-81.
31. Catala A. Five decades with polyunsaturated fatty acids: chemical synthesis, enzymatic formation, lipid peroxidation and its biological effects. J Lipids. 2013;2013:19.
32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. J Anal Biochem. 1979; 95:351-58.

Most read articles by the same author(s)